We are live on ! Find out more
HEC

Hudson Executive Capital Portfolio holdings

AUM $151M
1-Year Est. Return 60.14%
This Fund
S&P 500
This Quarter Est. Return
+2.17%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$1.32B
AUM Growth
+$284M
Cap. Flow
+$250M
Cap. Flow %
18.95%
Top 10 Hldgs %
98.9%
Holding
12
New
1
Increased
3
Reduced
2
Closed

Top Buys

Rank Stock Value
1
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$40.6M
2
CTLP
Cantaloupe
CTLP
+$21.1M

Top Sells

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$2.86M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$79.4K

Sector Composition

Rank Sector Weight
1 Financials 36.75%
2 Industrials 18.59%
3 Healthcare 12.13%
4 Technology 5.62%
5 Materials 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DB icon
1
Deutsche Bank
DB
$65.3B
$486M 36.75%
64,861,476
CATM
2
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$246M 18.59%
8,126,933
SPY icon
3
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$201M 15.22%
678,000
+479,000
+241% +$142M
IWM icon
4
PUT
iShares Russell 2000 ETF
IWM
$81.2B
$84.3M 6.38%
557,000
+328,000
+143% +$50.1M
CTLP
5
DELISTED
Cantaloupe
CTLP
$74.3M 5.62%
10,140,172
+2,944,452
+41% +$21.1M
CVRS
6
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$60.9M 4.61%
14,235,545
EGRX
7
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$45.8M 3.47%
810,365
-1,412
-0.2% -$79.4K
TVTY
8
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$39M 2.95%
+2,346,560
New +$40.6M
SMG icon
9
ScottsMiracle-Gro
SMG
$3.93B
$36.7M 2.78%
360,275
STOR
10
DELISTED
STORE Capital Corporation
STOR
$33.3M 2.52%
890,800
NTRA icon
11
Natera
NTRA
$37.9B
$12.4M 0.94%
378,589
ATRC icon
12
AtriCure
ATRC
$1.67B
$2.19M 0.17%
87,678
-100,000
-53% -$2.86M

Similar funds

Hudson Executive Capital's Q3 2019 Portfolio in Review

As of Q3 2019, Hudson Executive Capital held 12 positions worth $1.32B, up 27% from $1.04B the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Hudson Executive Capital deployed $250M of net new capital in Q3 2019, opening 1 new position and adding to 3 existing holdings. Its largest new stake was Tivity Health, Inc. Common Stock: 2,346,560 shares worth $39M.

By sector, the portfolio is most concentrated in Financials at 37% of assets, down from 48% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was AtriCure, an estimated $2.86M trimmed.

  • Hudson Executive Capital's largest Q3 2019 buy was Tivity Health, Inc. Common Stock: 2,346,560 shares worth $39M.
  • Hudson Executive Capital added most to Cantaloupe in Q3 2019, an estimated $21.1M increase.
  • Hudson Executive Capital's biggest Q3 2019 reduction was AtriCure, cutting an estimated $2.86M.
  • Hudson Executive Capital's ten largest holdings make up 99% of its $1.32B portfolio in Q3 2019.
  • Hudson Executive Capital opened 1 new position and closed 0 in Q3 2019.
  • Hudson Executive Capital's portfolio value rose 27% quarter-over-quarter to $1.32B.

Based on Hudson Executive Capital's 13F filing for Q3 2019, filed 14 Nov 2019.